Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic

Br J Dermatol. 2023 Mar 30;188(4):471-473. doi: 10.1093/bjd/ljac130.

Authors

David Gleeson¹, Jonathan N W N Barker², Francesca Capon³, Andrew E Pink¹, Richard T Woolf¹, Catherine H Smith¹, Satveer K Mahil¹

Affiliations

¹ St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, SE1 9RT, UK.
² St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, King's College London, London, SE1 7EP, UK.
³ Department of Medical and Molecular Genetics, King's College London, London, SE1 9RT, UK.

PMID: 36715624
DOI: 10.1093/bjd/ljac130

No abstract available

MeSH terms

Chronic Disease
Exanthema*
Humans
Janus Kinase Inhibitors* / therapeutic use
Psoriasis* / drug therapy
Treatment Outcome

Substances

Janus Kinase Inhibitors

Grants and funding